Cutler Group LP Alkermes Plc. Put Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 25, 2022	SELL	$22.0 - $31.87 $8,800 - $12,748	-400 Reduced 80.0%	100 $0
Q2 2022 Aug 04, 2022	SELL	$26.4 - $30.54 $277,200 - $320,670	-10,500 Reduced 95.45%	500 $0
Q1 2022 Apr 14, 2022	BUY	$23.07 - $27.99 $253,770 - $307,890	11,000 New	11,000 $8,000
Q2 2021 Jul 19, 2021	SELL	$18.78 - $25.15 $313,626 - $420,005	-16,700 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$18.21 - $23.2 $127,470 - $162,400	7,000 Added 72.16%	16,700 $20,000
Q4 2020 Jan 21, 2021	BUY	$15.39 - $22.1 $103,113 - $148,070	6,700 Added 223.33%	9,700 $4,000
Q2 2020 Jul 22, 2020	BUY	$13.31 - $19.41 $39,930 - $58,230	3,000 New	3,000 $5,000
Q1 2020 May 07, 2020	SELL	$13.06 - $21.24 $67,912 - $110,447	-5,200 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$17.29 - $21.74 $89,908 - $113,047	5,200 New	5,200 $0

363

182M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.8B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.